Cross-read of Q1 2026 prints from six analytical-instrument vendors: bioprocessing and semiconductor metrology are funding capex, while academic and core industrial demand stays cautious.
Revvity reported Q1 2026 revenue of $711 million and signed a letter of intent to sell its China Immunodiagnostics business for up to $200 million, citing persistent policy headwinds.
Specialty chemicals dealmaking through May 2026 leans on carve-outs and bolt-ons rather than transformative consolidation - BASF Coatings to Carlyle, an amended Honeywell-Johnson Matthey deal, Element Solutions on EFC.
FDA, EMA, and PMDA all build on ICH Q2(R2) and Q14, but their expectations for routine chemometric model upkeep, post-approval changes, and reference-method failures diverge in ways that shape submission strategy.
Two ECHA actions in early 2026 redraw the regulatory map for EU analytical-chemistry suppliers: n-hexane enters the SVHC Candidate List, and the universal PFAS restriction enters its final public consultation.
EMA's March 2026 Q&A on 3D-printed solid oral doses accepts inline NIR and Raman spectroscopy for unit-level rejection, anchoring personalised micro-batches in the QbD and RTRT framework.
Four mid-May physics.chem-ph preprints worth a PAT reader's time: vibrational eigenstate computation, polaritonic spectroscopy reliability, ML for photochemical decay, and DFT-accuracy ML force fields.
Three recent papers shift the calibration-transfer conversation: a low-rank fine-tuning method for deep Raman models, a vendor-to-vendor PDS/SST study, and single-compound shortcuts that sidestep paired transfer sets.
Six recent reviews map where hyperspectral imaging now sits as a process-analytics tool in pharma, food, recycling, and beyond - and where chemometrics, data hunger, and standards still hold it back.
Tornado Spectral Systems' separate brand has been retired into Bruker's process Raman portfolio. Timegate Instruments stays independent in Oulu, with a new Central European distributor signed for analytica 2026.
Waters Corporation posted $1.267 billion in Q1 2026 revenue, its first reporting period after closing the BD biosciences and diagnostics acquisition on February 9.
Sartorius installed a new chief in July 2025. Thermo Fisher and Danaher both have CFO and COO handovers landing in early 2026. Here is the running scorecard for analytical-instrument buyers.
Univariate SPC watches one number. A spectroscopic analyser produces a thousand. Multivariate SPC condenses them into two statistics that have been the standard since the early 1990s.
ASTM E2363 fixes four terms that engineers and scientists frequently misuse. A short reference for getting placement vocabulary right when scoping a process analytics project.
QbD is the broader regulatory philosophy that PAT serves. A primer on the ICH and FDA documents that built it, the vocabulary it introduced, and how process analytics fits inside it.
Six vendors that matter for bioreactor monitoring - what each one is good at, what they are not, and the methodology we used to scope the field down from the full process Raman market.
A companion to the non-ranked Spectrane process Raman buyer's guide. Ten vendors ordered on process-readiness, total cost of ownership, integration depth, chemometric maturity, and application coverage.
A composite of conversations with validation engineers working on pharmaceutical and biopharmaceutical PAT installations. The hardest parts of the job sit at the seams between project, quality, and operations.
A composite from mid-market plants in Central and Eastern Europe on what it means to buy process analytics from a vendor that is not Thermo, Agilent, or Mettler. The list is longer than the catalogue.
A partial least squares model rarely survives the move to a second instrument unchanged. A working protocol covers transfer set design, the standardisation method, and the acceptance criteria.
A calibration set defines what a chemometric model can predict, and where it will fail. Five planning decisions made up front determine whether validation later passes or unravels.